miR-C1 comprises microRNAs with a large number of significantly enriched gene targets, including the known EMT regulators ZEB2 and SIRT1. SIRT1 is known to suppress TGFβ-mediated EMT in breast cancer and kidney epithelial cells [35]. The gene discussed is ZEB2; the disease is breast cancer.